PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in PMV Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +8 vs. Q1 2022
- Shares held
- 61.1M
- +5.93M (+10.7%) vs. Q1 2022
- Total value
- $870.9M
- −$278.1M (−24.2%) vs. Q1 2022
- New holders
- 25
- 51 more added
- Sold out
- 17
- 16 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital, LLC | 3,498,636 | $49.9M | 3.16% | 00.0% | Unchanged |
| RTW Investments, LP | 4,395,677 | $62.6M | 1.62% | +523,523+13.5% | Added |
| JPMorgan Chase & Co | 4,919,323 | $70.1M | 0.01% | +1,713,836+53.5% | Added |
| State Street Corp | 5,171,490 | $73.7M | 0.00% | +2,605,945+101.6% | Added |
| OrbiMed Advisors LLC | 6,563,077 | $93.5M | 1.82% | −292,346−4.3% | Reduced |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −1,261,529−100.0% | Sold out |
| Viking Global Investors LPSuperinvestorViking Global Investors | 0 | $0 | 0.00% | −1,076,000−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −781,600−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −649,786−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −303,641−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −238,200−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −50,825−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −44,900−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −36,868−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −28,100−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −13,635−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −9,614−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −470−100.0% | Sold out |
| M&R Capital Management Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |